comparemela.com

Page 6 - Laura Sutcliffe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi (SNY) Q2 2021 Earnings Call Transcript

Sanofi (SNY) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript

GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

GLAXOSMITHKLINE : UBS remains Neutral

NOVARTIS AG : Buy rating from UBS | MarketScreener

Message : Required fields In a research note, UBS analyst Laura Sutcliffe has maintained his recommendation on the stock with a Buy rating. The target price continues to be set at CHF 96. © MarketScreener with dpa-AFX Analyser 2021 All news about NOVARTIS AG 09:30a

Galapagos NV (GLPG) Q1 2021 Earnings Call Transcript

Operator Good day, and thank you for standing by. Welcome to the Galapagos Financial Results Q1 2021 Conference Call. [Operator Instructions] Please be advised that today s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your first speaker today, Elizabeth Goodwin. Please go ahead. Elizabeth Goodwin Vice President of Investor Relations Thank you all, and welcome to our call today. I m Elizabeth Goodwin, Investor Relations, and the webcast that we re recording is going to be accessible via the Galapagos website homepage and will be available for download and replay later on today. I d like to remind everyone that we ll be making forward-looking statements during today s webcast. These forward-looking statements include remarks concerning future developments of the pipeline and our company and possible changes in the industry and competitive environment.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.